相似文献
1
Incidence of 4 Lysosomal Storage Disorders From 4 Years of Newborn Screening.
JAMA Pediatr. 2018 Jul 1;172(7):696-697. doi: 10.1001/jamapediatrics.2018.0263.
2
Newborn screening for lysosomal storage disorders.
Semin Perinatol. 2015 Apr;39(3):206-16. doi: 10.1053/j.semperi.2015.03.005. Epub 2015 Apr 16.
3
Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening.
Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):145-57. doi: 10.1016/j.beem.2014.08.004. Epub 2014 Aug 26.
4
Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
J Pediatr. 2015 Jan;166(1):172-7. doi: 10.1016/j.jpeds.2014.09.023. Epub 2014 Oct 18.
5
Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.
J Inherit Metab Dis. 2018 Mar;41(2):209-219. doi: 10.1007/s10545-017-0098-3. Epub 2017 Nov 15.
6
Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience.
J Pediatr. 2017 Nov;190:130-135. doi: 10.1016/j.jpeds.2017.06.048. Epub 2017 Jul 17.
7
Current Status and Use of Resources of Lysosomal Storage Diseases: Analysis of a Spanish Claims Database.
Endocr Metab Immune Disord Drug Targets. 2020;20(2):263-270. doi: 10.2174/1871530319666190807162344.
8
Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system.
Mol Genet Metab. 2017 May;121(1):16-21. doi: 10.1016/j.ymgme.2017.03.001. Epub 2017 Mar 9.
9
Lysosomal storage disorders: A review of the musculoskeletal features.
J Paediatr Child Health. 2016 Mar;52(3):262-71. doi: 10.1111/jpc.13122.
10
Newborn bloodspot screening for lysosomal storage disorders.
J Pediatr. 2011 Jul;159(1):7-13.e1. doi: 10.1016/j.jpeds.2011.02.026. Epub 2011 Apr 13.
引用本文的文献
1
Analysis of the Effect of Demographic Variables on Lysosomal Enzyme Activities in the Missouri Newborn Screening Program.
Int J Neonatal Screen. 2025 Jun 19;11(2):48. doi: 10.3390/ijns11020048.
2
Effect of newborn genomic screening for lysosomal storage disorders: a cohort study in China.
Genome Med. 2025 May 12;17(1):52. doi: 10.1186/s13073-025-01483-z.
3
Five years of newborn screening for Pompe, Mucopolysaccharidosis type I, Gaucher, and Fabry diseases in Oregon.
Mol Genet Metab Rep. 2025 Apr 15;43:101221. doi: 10.1016/j.ymgmr.2025.101221. eCollection 2025 Jun.
4
Gastrointestinal Manifestations and Low- Protocol in a Cohort of Fabry Disease Adult Patients.
Nutrients. 2023 Jan 28;15(3):658. doi: 10.3390/nu15030658.
5
Obtaining the best igRNAs for bystander-less correction of all ABE-reversible pathogenic SNVs using high-throughput screening.
Mol Ther. 2023 Apr 5;31(4):1167-1176. doi: 10.1016/j.ymthe.2023.01.028. Epub 2023 Feb 1.
6
The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants.
Orphanet J Rare Dis. 2023 Jan 9;18(1):8. doi: 10.1186/s13023-022-02599-w.
7
Fabry disease - a multisystemic disease with gastrointestinal manifestations.
Gut Microbes. 2022 Jan-Dec;14(1):2027852. doi: 10.1080/19490976.2022.2027852.
8
Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans.
Diagnostics (Basel). 2021 Jul 27;11(8):1347. doi: 10.3390/diagnostics11081347.
9
Current and emerging pharmacotherapy for Gaucher disease in pediatric populations.
Expert Opin Pharmacother. 2021 Aug;22(11):1489-1503. doi: 10.1080/14656566.2021.1902989. Epub 2021 Mar 25.
10
Epidemiology of Mucopolysaccharidoses Update.
Diagnostics (Basel). 2021 Feb 10;11(2):273. doi: 10.3390/diagnostics11020273.
本文引用的文献
1
Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience.
J Pediatr. 2017 Nov;190:130-135. doi: 10.1016/j.jpeds.2017.06.048. Epub 2017 Jul 17.
2
Newborn screening for lysosomal storage disorders.
Semin Perinatol. 2015 Apr;39(3):206-16. doi: 10.1053/j.semperi.2015.03.005. Epub 2015 Apr 16.
3
Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
J Pediatr. 2015 Jan;166(1):172-7. doi: 10.1016/j.jpeds.2014.09.023. Epub 2014 Oct 18.
4
Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.
Clin Chim Acta. 2013 Sep 23;424:12-8. doi: 10.1016/j.cca.2013.05.001. Epub 2013 May 7.
Zotero 插件